Follow The Filings

ELTX Elicio Therapeutics Inc.

Health Care, filed as ELICIO THERAPEUTICS INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.4%
  • $2.3M
  • 1 new

In 2026 Q3 Himanshu Shah opened a position in Elicio Therapeutics.

Who owns this now

Largest portfolio weights among holders, up to 0.4% (Himanshu Shah, Shah Capital Management). Not free-float ownership.

  1. Himanshu Shah New 0.38%

Who owns ELTX

Sorted by value, long equity only, as of 2026 Q3.

History
Himanshu Shah, Shah Capital Management 0.38% New 0.38% 1,250,000 $2.3M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ELTX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ELTX insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 4 stock grants and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
DEF 14A Filing Doc
8-K 5.08,8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 7.01 Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
10-K/A Filing Doc
424B5 Filing Doc
8-K 1.01,1.02 Filing Doc
8-K 2.02 Filing Doc
10-K Filing Doc
8-K 2.02 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated 10 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$35.2M -$51.9M -$39.57M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $16.35M $20.69M $19.31M
Total non-current assets * $10.8M $7.48M $6.55M
Total assets $27.15M $28.18M $25.86M
Total current liabilities $9.77M $11.52M $8.11M
Total non-current liabilities * $6.01M $27.97M $16.12M
Total equity $11.37M -$11.31M $1.64M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$32.69M -$37.07M -$36.95M
Cash from investing -$32,000 -$84,000 -$16,000
Cash from financing $38.61M $42.32M $36.7M
Net change in cash $5.89M $5.19M -$0.225M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Q3 2026

Period archive